Reversible control of CAR T cells through PROTAC compound targeting bromodomain mutant. // Molecular Therapy: Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2950329926001566?dgcid=rss_sd_all
Reversible control of CAR T cells through PROTAC compound targeting bromodomain mutant. Molecular Therapy: Oncology. https://www.sciencedirect.com/science/article/pii/S2950329926001566?dgcid=rss_sd_all
“Reversible control of CAR T cells through PROTAC compound targeting bromodomain mutant.” Molecular Therapy: Oncology.
@article{article119277,
title = {Reversible control of CAR T cells through PROTAC compound targeting bromodomain mutant},
journal = {Molecular Therapy: Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2950329926001566?dgcid=rss_sd_all}
}